Not since the swimmer Lia Thomas has a college athlete or team put the fiercely contested issue of transgender rights in sports under such a bright spotlight.
Sarepta will pay Arrowhead Pharmaceuticals $500 million upfront, make a $325 million equity investment, plus pay $250 million over five years, and more.